Literature DB >> 22391550

Detection and characterization of VIM-31, a new variant of VIM-2 with Tyr224His and His252Arg mutations, in a clinical isolate of Enterobacter cloacae.

Pierre Bogaerts1, Carine Bebrone, Te-Din Huang, Warda Bouchahrouf, Yves Degheldre, Ariane Deplano, Kurt Hoffmann, Youri Glupczynski.   

Abstract

We report the first description of the metallo-β-lactamase VIM-31, a new variant of VIM-2 with Tyr224His and His252Arg mutations, in Enterobacter cloacae 11236, which was isolated from blood specimens of a patient with colonic adenocarcinoma in Belgium. bla(VIM-31) was found on a class 1 integron located on a self-transferable but not typeable 42-kb plasmid. Compared to values published elsewhere for VIM-2, the purified VIM-31 enzyme showed weaker catalytic efficiency against all the tested beta-lactam agents (except for ertapenem), resulting from lower k(cat) (except for ertapenem) and higher K(m) values for VIM-31.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391550      PMCID: PMC3370733          DOI: 10.1128/AAC.06249-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Update of the standard numbering scheme for class B beta-lactamases.

Authors:  Gianpiero Garau; Isabel García-Sáez; Carine Bebrone; Christine Anne; Paola Mercuri; Moreno Galleni; Jean-Marie Frère; Otto Dideberg
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

2.  Interaction between class B beta-lactamases and suicide substrates of active-site serine beta-lactamases.

Authors:  C Prosperi-Meys; G Llabres; D de Seny; R P Soto; M H Valladares; N Laraki; J M Frere; M Galleni
Journal:  FEBS Lett       Date:  1999-01-25       Impact factor: 4.124

3.  Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-beta-lactamases.

Authors:  Claudia Scotta; Carlos Juan; Gabriel Cabot; Antonio Oliver; Jorge Lalucat; Antonio Bennasar; Sebastián Albertí
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

4.  Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-beta-lactamase IMP-1 produced by Escherichia coli.

Authors:  N Laraki; N Franceschini; G M Rossolini; P Santucci; C Meunier; E de Pauw; G Amicosante; J M Frère; M Galleni
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

5.  Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli.

Authors:  T Kieser
Journal:  Plasmid       Date:  1984-07       Impact factor: 3.466

6.  Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.

Authors:  E H Lee; M H Nicolas; M D Kitzis; G Pialoux; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  PCR mapping of integrons reveals several novel combinations of resistance genes.

Authors:  C Lévesque; L Piché; C Larose; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis.

Authors:  M J Struelens; F Rost; A Deplano; A Maas; V Schwam; E Serruys; M Cremer
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

9.  Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii.

Authors:  Jing-Jou Yan; Wen-Chien Ko; Chin-Luan Chuang; Jiunn-Jong Wu
Journal:  J Antimicrob Chemother       Date:  2002-10       Impact factor: 5.790

10.  Characterization of a new integron containing VIM-2, a metallo- beta-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae.

Authors:  Seok Hoon Jeong; Kyungwon Lee; Yunsop Chong; Jong Hwa Yum; Sang Hee Lee; Hyuk Jin Choi; Jeong Man Kim; Kil Ho Park; Byung Hoon Han; Sang Wook Lee; Tae Sik Jeong
Journal:  J Antimicrob Chemother       Date:  2003-02       Impact factor: 5.790

View more
  5 in total

Review 1.  B1-Metallo-β-Lactamases: Where Do We Stand?

Authors:  Maria F Mojica; Robert A Bonomo; Walter Fast
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

2.  Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Krystyna M Kazmierczak; Sharon Rabine; Meredith Hackel; Robert E McLaughlin; Douglas J Biedenbach; Samuel K Bouchillon; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

3.  Evolution of Metallo-β-lactamases: Trends Revealed by Natural Diversity and in vitro Evolution.

Authors:  María-Rocío Meini; Leticia I Llarrull; Alejandro J Vila
Journal:  Antibiotics (Basel)       Date:  2014-07-01

4.  Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases.

Authors:  Laura Martínez-García; José M González-Alba; Fernando Baquero; Rafael Cantón; Juan Carlos Galán
Journal:  MBio       Date:  2018-05-08       Impact factor: 7.867

5.  Comprehensive exploration of the translocation, stability and substrate recognition requirements in VIM-2 lactamase.

Authors:  John Z Chen; Douglas M Fowler; Nobuhiko Tokuriki
Journal:  Elife       Date:  2020-06-08       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.